Valuation: Merck KGaA

Capitalization 62.89B 66.08B 58.28B 51.84B 93.58B 5,607B 104B 726B 268B 2,302B 248B 243B 10,048B P/E ratio 2024 *
21.6x
P/E ratio 2025 * 18.5x
Enterprise value 70.06B 73.61B 64.93B 57.75B 104B 6,247B 116B 808B 298B 2,565B 276B 270B 11,193B EV / Sales 2024 *
3.31x
EV / Sales 2025 * 3.08x
Free-Float
-
Yield 2024 *
1.62%
Yield 2025 * 1.73%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.07%
1 week+1.58%
Current month+2.15%
1 month-4.11%
3 months-15.06%
6 months-15.85%
Current year+0.38%
More quotes
1 week
138.85
Extreme 138.85
146.30
1 month
137.50
Extreme 137.5
154.00
Current year
137.50
Extreme 137.5
177.00
1 year
134.30
Extreme 134.3
177.00
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
70.68
Extreme 70.68
231.50
More quotes
Director TitleAgeSince
Chief Executive Officer 63 2021-04-30
Director of Finance/CFO 54 2023-06-30
Chief Tech/Sci/R&D Officer - 2022-02-28
Manager TitleAgeSince
Director/Board Member - 2019-04-25
Director/Board Member 62 2012-04-30
Director/Board Member 75 2014-05-08
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.08%+1.58%+1.87%-35.57%66.08B
-0.77%+0.78%+0.45%-23.48%8.31B
0.00%+1.20%+22.80%+42.20%6.24B
+7.69%-2.08%+87.82%+114.91%6.16B
+5.37%-2.39%+13.19%-4.13%5.59B
-3.84%-6.57%-7.04%-34.66%3.1B
-0.97%+0.25%+21.39%+29.37%2.26B
+0.16%-0.78%+36.53%+27.17%2.03B
+0.57%-2.74%-31.97%+28.61%2.03B
-.--%-.--% - - 1.64B
Average +0.81%-0.10%+16.12%+16.05% 10.34B
Weighted average by Cap. +0.52%+0.91%+9.03%-14.99%
See all sector performances

Financials

2024 *2025 *
Net sales 21.15B 22.22B 19.6B 17.43B 31.47B 1,886B 34.88B 244B 90.09B 774B 83.42B 81.62B 3,379B 22.09B 23.21B 20.47B 18.21B 32.87B 1,970B 36.43B 255B 94.11B 809B 87.14B 85.26B 3,530B
Net income 2.94B 3.08B 2.72B 2.42B 4.37B 262B 4.84B 33.88B 12.51B 107B 11.58B 11.33B 469B 3.39B 3.56B 3.14B 2.79B 5.04B 302B 5.59B 39.1B 14.43B 124B 13.37B 13.08B 541B
Net Debt 7.17B 7.53B 6.65B 5.91B 10.67B 639B 11.83B 82.75B 30.55B 263B 28.29B 27.68B 1,146B 5.24B 5.5B 4.85B 4.32B 7.79B 467B 8.63B 60.42B 22.3B 192B 20.65B 20.21B 836B
More financial data * Estimated data
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Employees
62,255
Calendar
More about the company
Date Price Change Volume
24-12-10 144.65 +2.08% 444,777
24-12-09 141.70 +1.40% 369,191
24-12-06 139.75 -0.14% 450,481
24-12-05 139.95 -0.74% 265,041
24-12-04 141.00 -0.98% 308,110

Delayed Quote Xetra, December 10, 2024 at 11:35 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A
surperformance-ratings-light-chart MERCK-KGAAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
144.65EUR
Average target price
183.75EUR
Spread / Average Target
+27.03%
Consensus

Quarterly revenue - Rate of surprise